新辅助向治疗对切除肺腺癌的瘤微环境的影响
Ling Yi1, Heng Yao2, Zhexin Bai3
1Department of Cancer Research Center, Beijing Chest Hospital, Capital Medical University, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, China.
Cellular oncology (Dordrecht, Netherlands)
|August 27, 2025
概括
非小细胞肺癌 (NSCLC) 的新辅助向治疗增加了瘤微环境 (TME) 中的免疫细胞密度. 具有重大病理反应 (MPR) 和ALK突变的患者表现出更高的免疫细胞透率和更好的生存率.
科学领域:
- 癌症学
- 免疫学
- 胸部手术
背景情况:
- 新辅助向治疗是一种可切除的非小细胞肺癌 (NSCLC) 的有希望的策略.
- 针对性治疗后分析瘤微环境 (TME) 免疫状态对于了解治疗影响和开发协同方法至关重要.
研究的目的:
- 在可切除肺腺癌 (LUAD) 患者接受新辅助向治疗后,研究TME的免疫状态.
- 将TME免疫细胞透与病理反应和患者的结果相关联.
主要方法:
- 42名可切除的LUAD患者接受了新辅助向治疗 (ALK/ EGFR突变的TKI).
- 使用多重免疫光技术分析TME免疫细胞组成.
- 评估了病理反应 (pCR,MPR) 和无进展生存期 (PFS).
主要成果:
- 与非MPR和EGFR组相比,获得重大病理反应 (MPR) 和ALK突变的患者的CD8+T细胞,GZMB+CD8+T细胞,PD-1+CD8+T细胞,巨细胞和M1巨细胞密度显著增加.
- 在CD8+ T细胞和各种免疫标志物之间以及CD8+ T细胞和巨细胞群体之间观察到正相关性.
- 在MPR患者中,PFS延长的趋势显现,而TME中较高的巨细胞密度与PFS延长有显著的关联.
结论:
- 针对TKI的治疗有效地减少了瘤负担,促进了完整的手术切除.
- MPR和ALK突变与TME炎症免疫细胞密度的增加有关.
- 在TME中较高的巨细胞密度与明显更长的无进展生存时间相关.
更多相关视频
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
18.1K
06:03Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
17.3K
相关概念视频
02:17The Tumor Microenvironment
6.8K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
01:27Tumor Immunotherapy
658
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
658